b 180 (Minocycline ER 135 mg)
Pill imprint b 180 has been identified as Minocycline hydrochloride extended-release 135 mg.
Minocycline is used in the treatment of acne; bacterial infection; skin and structure infection; periodontitis; actinomycosis (and more), and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy. Minocycline 135 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for b 180 (Minocycline ER 135 mg)
Minocycline hydrochloride extended-release
- Imprint:
-
b
180 - Strength:
- 135 mg
- Color:
- Brown
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Tetracyclines
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00555-0180
More resources
Minocycline hydrochloride extended-release is associated with the treatment of:
Search Again
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
